Phosphorus (Decision/Risk Analysis) Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

Phosphorus (Decision/Risk Analysis) General Information

Description

Developer of a genomics-based test designed to improve human health. The company's genetic test can be used to diagnose preventative diseases before it happens, as well as offers a computational genomic data network, enabling clinicians to help patients be proactive about their health.

Contact Information

Website
www.phosphorus.com
Formerly Known As
Recombine Genomics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1140 Broadway
  • Suite 1203
  • New York, NY 10001
  • United States
Primary Industry
Decision/Risk Analysis
Acquirer
Kindbody
Vertical(s)
Life Sciences
Corporate Office
  • 1140 Broadway
  • Suite 1203
  • New York, NY 10001
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phosphorus (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 07-Jun-2022 Completed Generating Revenue
3. Early Stage VC (Series A3) 20-Aug-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Sep-2019 $13.4M $23.4M Completed Generating Revenue
1. Early Stage VC (Series A) 27-Jul-2016 $10M $10M Completed Startup
To view Phosphorus (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Phosphorus (Decision/Risk Analysis) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A4
Series A3
Series A2
Series A1 8,250,927 $0.000100 $0.08 $1.01 $1.01 1x $1.01 18.98%
Series A 8,243,331 $0.000100 $0.1 $1.21 $1.21 1x $1.09 21.04%
To view Phosphorus (Decision/Risk Analysis)’s complete cap table history, request access »

Phosphorus (Decision/Risk Analysis) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genomics-based test designed to improve human health. The company's genetic test can be used to diagnose
Decision/Risk Analysis
New York, NY
33 As of 2022

Creve Coeur, MO
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phosphorus (Decision/Risk Analysis) Competitors (27)

One of Phosphorus (Decision/Risk Analysis)’s 27 competitors is PierianDx, a Private Equity-Backed company based in Creve Coeur, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PierianDx Private Equity-Backed Creve Coeur, MO
Congenica Formerly VC-backed Cambridge, United Kingdom
Paige Formerly VC-backed New York, NY
Genalice Formerly PE-Backed Harderwijk, Netherlands
Ibex Medical Analytics Venture Capital-Backed Tel Aviv, Israel
You’re viewing 5 of 27 competitors. Get the full list »

Phosphorus (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phosphorus (Decision/Risk Analysis) Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Echo Investment Capital PE/Buyout Minority
FirstMark Capital Venture Capital Minority
Gaingels Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Phosphorus (Decision/Risk Analysis) FAQs

  • When was Phosphorus (Decision/Risk Analysis) founded?

    Phosphorus (Decision/Risk Analysis) was founded in 2016.

  • Where is Phosphorus (Decision/Risk Analysis) headquartered?

    Phosphorus (Decision/Risk Analysis) is headquartered in New York, NY.

  • What is the size of Phosphorus (Decision/Risk Analysis)?

    Phosphorus (Decision/Risk Analysis) has 33 total employees.

  • What industry is Phosphorus (Decision/Risk Analysis) in?

    Phosphorus (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Phosphorus (Decision/Risk Analysis) a private or public company?

    Phosphorus (Decision/Risk Analysis) is a Private company.

  • What is Phosphorus (Decision/Risk Analysis)’s current revenue?

    The current revenue for Phosphorus (Decision/Risk Analysis) is .

  • How much funding has Phosphorus (Decision/Risk Analysis) raised over time?

    Phosphorus (Decision/Risk Analysis) has raised $31.4M.

  • Who are Phosphorus (Decision/Risk Analysis)’s investors?

    Echo Investment Capital, FirstMark Capital, Gaingels, , and are 5 of 11 investors who have invested in Phosphorus (Decision/Risk Analysis).

  • Who are Phosphorus (Decision/Risk Analysis)’s competitors?

    PierianDx, Congenica, Paige, Genalice, and Ibex Medical Analytics are some of the 27 competitors of Phosphorus (Decision/Risk Analysis).

  • When was Phosphorus (Decision/Risk Analysis) acquired?

    Phosphorus (Decision/Risk Analysis) was acquired on 07-Jun-2022.

  • Who acquired Phosphorus (Decision/Risk Analysis)?

    Phosphorus (Decision/Risk Analysis) was acquired by Kindbody.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process